Malignant Urinary System Neoplasm — Trials

Malignant Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 888
Recruiting: 467
Ph III recruiting: 52
Growth YoY: +13.3%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (556)

clinicaltrialsPublishedShowing 801–850 of 3,853 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06109857	Bladder Bank (a Prospective Banking Study)	recruiting	—	1,500	Mayo ClinicOTHER	1	Mar 16, 2026	clinicaltrials
NCT07465458	Radiofrequency Ablation Multicenter Observational Study in Renal Oncology Patients(RASROP-003)	not yet recruiting	—	226	Humanitas Hospital, ItalyOTHER	2	Mar 16, 2026	clinicaltrials